Iovance Biotherapeutics (IOVA) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Iovance Biotherapeutics (IOVA) Halted on LUDP
February 25, 2020 1:18 PM ESTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
... MoreUPDATE: Iovance Biotherapeutics (IOVA) Said to Explore Potential Sale - Bloomberg
February 25, 2020 1:17 PM EST(Updated - February 25, 2020 1:21 PM EST)
Iovance Biotherapeutics (NASDAQ: IOVA) is exploring a sale and held preliminary talks with potential buyers, according to Bloomberg, citing people familiar with the matter.
It is working with a financial adviser after receiving takeover interest.
... More